Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rogier Versteeg

Showing results (41-50 of 143) with videos related to

Pageof 15
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2011
Methylated RASSF1a is the first specific DNA marker for minimal residual disease testing in neuroblastomaJanine Stutterheim, Fatima Ait Ichou, Emmy den Ouden, et al.
International Journal of Cancer|December 7, 2007
Dickkopf-3 expression is a marker for neuroblastic tumor maturation and is down-regulated by MYCNArjen Koppen, Rachida Ait-Aissa, Jan Koster, et al.
Plos One|December 31, 2015
DNA-Dependent Protein Kinase As Molecular Target for Radiosensitization of Neuroblastoma CellsM Emmy M Dolman, Ida van der Ploeg, Jan Koster, et al.
Molecular Carcinogenesis|May 11, 2011
Dissection of the oncogenic MYCN transcriptional network reveals a large set of clinically relevant cell cycle genes as drivers of neuroblastoma tumorigenesisDerek M Murphy, Patrick G Buckley, Kenneth Bryan, et al.
Plos One|December 15, 2010
Efficient double fragmentation ChIP-seq provides nucleotide resolution protein-DNA binding profilesMichal Mokry, Pantelis Hatzis, Ewart de Bruijn, et al.
Oncogene|November 2, 2004
The Phox2B homeobox gene is mutated in sporadic neuroblastomasVera van Limpt, Alexander Schramm, Arjan van Lakeman, et al.
Investigational New Drugs|September 7, 2014
Targeting polo-like kinase 1 by NMS-P937 in osteosarcoma cell lines inhibits tumor cell growth and partially overcomes drug resistanceValeria Sero, Elisa Tavanti, Serena Vella, et al.
International Journal of Cancer|January 15, 2009
The low-affinity neurotrophin receptor, p75, is upregulated in ganglioneuroblastoma/ganglioneuroma and reduces tumorigenicity of neuroblastoma cells in vivoJohannes H Schulte, Falk Pentek, Wolfgang Hartmann, et al.
Cancer Letters|June 1, 2005
Biological effects of TrkA and TrkB receptor signaling in neuroblastomaAlexander Schramm, Johannes H Schulte, Kathy Astrahantseff, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 16, 2009
Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cellsJan J Molenaar, Marli E Ebus, Dirk Geerts, et al.
Pageof 15

Showing results (41-50 of 143) with videos related to

Sort By:
Pageof 15
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2011
Methylated RASSF1a is the first specific DNA marker for minimal residual disease testing in neuroblastomaJanine Stutterheim, Fatima Ait Ichou, Emmy den Ouden, et al.
International Journal of Cancer|December 7, 2007
Dickkopf-3 expression is a marker for neuroblastic tumor maturation and is down-regulated by MYCNArjen Koppen, Rachida Ait-Aissa, Jan Koster, et al.
Plos One|December 31, 2015
DNA-Dependent Protein Kinase As Molecular Target for Radiosensitization of Neuroblastoma CellsM Emmy M Dolman, Ida van der Ploeg, Jan Koster, et al.
Molecular Carcinogenesis|May 11, 2011
Dissection of the oncogenic MYCN transcriptional network reveals a large set of clinically relevant cell cycle genes as drivers of neuroblastoma tumorigenesisDerek M Murphy, Patrick G Buckley, Kenneth Bryan, et al.
Plos One|December 15, 2010
Efficient double fragmentation ChIP-seq provides nucleotide resolution protein-DNA binding profilesMichal Mokry, Pantelis Hatzis, Ewart de Bruijn, et al.
Oncogene|November 2, 2004
The Phox2B homeobox gene is mutated in sporadic neuroblastomasVera van Limpt, Alexander Schramm, Arjan van Lakeman, et al.
Investigational New Drugs|September 7, 2014
Targeting polo-like kinase 1 by NMS-P937 in osteosarcoma cell lines inhibits tumor cell growth and partially overcomes drug resistanceValeria Sero, Elisa Tavanti, Serena Vella, et al.
International Journal of Cancer|January 15, 2009
The low-affinity neurotrophin receptor, p75, is upregulated in ganglioneuroblastoma/ganglioneuroma and reduces tumorigenicity of neuroblastoma cells in vivoJohannes H Schulte, Falk Pentek, Wolfgang Hartmann, et al.
Cancer Letters|June 1, 2005
Biological effects of TrkA and TrkB receptor signaling in neuroblastomaAlexander Schramm, Johannes H Schulte, Kathy Astrahantseff, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 16, 2009
Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cellsJan J Molenaar, Marli E Ebus, Dirk Geerts, et al.
Pageof 15